Legionella pneumophila type II protein secretion promotes virulence in the A/J mouse model of Legionnaires' disease pneumonia

被引:120
作者
Rossier, O [1 ]
Starkenburg, SR [1 ]
Cianciotto, NP [1 ]
机构
[1] Northwestern Univ, Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA
关键词
D O I
10.1128/IAI.72.1.310-321.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Legionella pneumophila, the gram-negative agent of Legionnaires' disease, possesses type IV pili and a type II protein secretion (Lsp) system, both of which are dependent upon the PilD prepilin peptidase. By analyzing multiple pilD mutants and various types of Lsp mutants as well as performing trans-complementation of these mutants, we have confirmed that PilD and type II secretion genes are required for L. pneumophila infection of both amoebae and human macrophages. Based upon a complete analysis of IspDE, lspF, and lspG mutants, we found that the type II system controls the secretion of protease, RNase, lipase, phospholipase A, phospholipase C, lysophospholipase A, and tartrate-sensitive and tartrate-resistant acid phosphatase activities and influences the appearance of colonies. Examination of the developing L. pneumophila genome database indicated that the organism has two other loci (IspC and IspLM) that are predicted to promote secretion and thus a set of genes that is comparable to the type II secretion genes in other gram-negative bacteria. In contrast to lsp mutants, L. pneumophila pilus mutants lacking either the PilQ secretin, the PspA pseudopilin, or pilin were not defective for colonial growth, secreted activities, or intracellular replication. L. pneumophila dot/icm mutants were also not impaired for type II-dependent exoenzymes. Upon intratracheal inoculation into A/J mice, IspDE, lspF, and pilD mutants, but not pilus mutants, exhibited a reduced ability to grow in the lung, as measured by competition assays. The lspF mutant was also defective in an in vivo kinetic assay. Examination of infected mouse sera revealed that type II secreted proteins are expressed in vivo. Thus, the L. pneumophila Lsp system is a virulence factor and the only type II secretion system linked to intracellular infection.
引用
收藏
页码:310 / 321
页数:12
相关论文
共 100 条
[1]   Temporal pore formation-mediated egress from macrophages and alveolar epithelial cells by Legionella pneumophila [J].
Alli, OAT ;
Gao, LY ;
Pedersen, LL ;
Zink, S ;
Radulic, M ;
Doric, M ;
Abu Kwaik, Y .
INFECTION AND IMMUNITY, 2000, 68 (11) :6431-6440
[2]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[3]   Secreted enzymatic activities of wild-type and pilD-deficient Legionella pneumophila [J].
Aragon, V ;
Kurtz, S ;
Flieger, A ;
Neumeister, B ;
Cianciotto, NP .
INFECTION AND IMMUNITY, 2000, 68 (04) :1855-1863
[4]   Legionella pneumophila genes that encode lipase and phospholipase C activities [J].
Aragon, V ;
Rossier, O ;
Cianciotto, NP .
MICROBIOLOGY-SGM, 2002, 148 :2223-2231
[5]   Legionella pneumophila major acid phosphatase and its role in intracellular infection [J].
Aragon, V ;
Kurtz, S ;
Cianciotto, NP .
INFECTION AND IMMUNITY, 2001, 69 (01) :177-185
[6]  
Ausubel FA, 1995, CURRENT PROTOCOLS MO
[7]   A novel type 11 secretion system in Pseudomonas aeruginosa [J].
Ball, G ;
Durand, É ;
Lazdunski, A ;
Filloux, A .
MOLECULAR MICROBIOLOGY, 2002, 43 (02) :475-485
[8]   PROTEIN SECRETION IN PSEUDOMONAS-AERUGINOSA - CHARACTERIZATION OF 7 XCP GENES AND PROCESSING OF SECRETORY APPARATUS COMPONENTS BY PREPILIN PEPTIDASE [J].
BALLY, M ;
FILLOUX, A ;
AKRIM, M ;
BALL, G ;
LAZDUNSKI, A ;
TOMMASSEN, J .
MOLECULAR MICROBIOLOGY, 1992, 6 (09) :1121-1131
[9]   LEGIONELLA-PNEUMOPHILA SEROGROUP-14 ISOLATED FROM PATIENTS WITH FATAL PNEUMONIA [J].
BENSON, RF ;
THACKER, WL ;
WILKINSON, HW ;
FALLON, RJ ;
BRENNER, DJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (02) :382-382
[10]   ISOLATION AND CHARACTERIZATION OF A 7TH SEROGROUP OF LEGIONELLA-PNEUMOPHILA [J].
BIBB, WF ;
ARNOW, PM ;
DELLINGER, DL ;
PERRYMAN, SR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 17 (02) :346-348